EDESA BIOTECH INC (EDSA) Forecast, Price Target & Analyst Ratings

NASDAQ:EDSACA27966L3065

Current stock price

7.35 USD
+0.12 (+1.66%)
At close:
7.83 USD
+0.48 (+6.53%)
Pre-Market:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDESA BIOTECH INC (EDSA).

Forecast Snapshot

Consensus Price Target

Price Target
$11.22
+ 52.65% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 12, 2026
Period
Q2 / 2026
EPS Estimate
-$0.28
Revenue Estimate

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.22
Upside
+ 52.65%
From current price of $7.35 to mean target of $11.22, Based on 8 analyst forecasts
Low
$5.05
Median
$9.18
High
$19.95

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for EDSA. The average price target is 11.22 USD. This implies a price increase of 52.65% is expected in the next year compared to the current price of 7.35.

Analyst Ratings & History

Current Analyst Ratings

EDSA Current Analyst RatingEDSA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

EDSA Historical Analyst RatingsEDSA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
EDSA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about EDSA.
In the previous month the buy percentage consensus was at a similar level.
EDSA was analyzed by 8 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-11-03HC Wainwright & Co.Reiterate Buy -> Buy
2025-03-13HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-20HC Wainwright & Co.Reiterate Buy -> Buy
2024-06-28HC Wainwright & Co.Reiterate Buy -> Buy
2024-02-14HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-29HC Wainwright & Co.Maintains Buy -> Buy
2023-11-22HC Wainwright & Co.Reiterate Buy -> Buy
2023-10-12Brookline CapitalMaintains Buy -> Buy
2023-08-15HC Wainwright & Co.Maintains Buy -> Buy
2023-05-24HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-15HC Wainwright & Co.Reiterate Buy
2023-02-14HC Wainwright & Co.Reiterate Buy
2021-12-20HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 12, 2026
Period
Q2 / 2026
EPS Estimate
-$0.28
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
7.07%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
39.71%
EPS (3 Months)
8.89%

Next Earnings Summary

EDSA is expected to report earnings on 5/12/2026. The consensus EPS estimate for the next earnings is -0.28 USD and the consensus revenue estimate is 0 USD.

Full Analyst Estimates 2026 - 2028

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
EDSA revenue by date.EDSA revenue by date.
211.9K
-7.18%
410.9K
93.91%
328.8K
-19.98%

-100.00%
EBITDA
YoY % growth
EDSA ebitda by date.EDSA ebitda by date.
-4.89M
3.08%
-2.827M
42.18%
-6.343M
-124.36%
-12.24M
-271.46%
N/A
22.54%
N/A
50.48%
N/A
24.46%
N/AN/AN/AN/A
EBIT
YoY % growth
EDSA ebit by date.EDSA ebit by date.
-5.078M
2.80%
-2.832M
44.23%
-6.401M
-126.01%
-24.897M
-269.97%
-22.338M
22.42%
-9.213M
49.80%
-8.568M
23.94%
-7.562M
-7.80%
-12.444M
-64.56%
-25.245M
-102.87%
-26.928M
-6.67%
Operating Margin
EDSA operating margin by date.EDSA operating margin by date.
-2,396.55%-689.24%-1,946.72%N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
EDSA eps by date.EDSA eps by date.
N/AN/AN/A-7.31
-152.53%
-10.25
38.24%
-4.62
58.50%
-2.65
36.72%
-1.61
30.05%
-1.50
-10.82%
-1.77
-18.64%
-1.32
25.57%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.28
7.07%
-0.48
-90.40%
-0.45
-41.31%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-2.244M
-36.92%
-4.743M
-149.15%
-4.182M
-69.29%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EDSA Yearly Revenue VS EstimatesEDSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 200K 400K 600K 800K 1M
EDSA Yearly EPS VS EstimatesEDSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
2.61%
EPS Next 5 Year
7.10%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

EDESA BIOTECH INC / EDSA Forecast FAQ

Can you provide the average price target for EDESA BIOTECH INC stock?

8 analysts have analysed EDSA and the average price target is 11.22 USD. This implies a price increase of 52.65% is expected in the next year compared to the current price of 7.35.

Can you provide the upcoming earnings date for EDESA BIOTECH INC?

EDESA BIOTECH INC (EDSA) will report earnings on 2026-05-12.

What are the consensus estimates for EDSA stock next earnings?

The consensus EPS estimate for the next earnings of EDESA BIOTECH INC (EDSA) is -0.28 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for EDSA stock?

The consensus rating for EDESA BIOTECH INC (EDSA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.